ReviewMolecular medicine reports2026
Evolving role of biomarkers beyond prostate‑specific antigen in refining prostate cancer screening: From blood‑based tests to urinary and genetic markers (Review).
Luxi Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.